Teleon Surgical BV offers intraocular lenses (IOL) such as ACUNEX, LENTIS, and FEMTIS, as well as the ALLY adaptive cataract treatment system from LENSAR. The company provides solutions for cataract and refractive surgery.

Teleon Surgical BV

Bausch Surgical is involved in the development and provision of surgical equipment and instruments for ophthalmic procedures, particularly in cataract, refractive, and retina surgeries.

Bausch Surgical

JelliSee is an innovative medical device company that has developed a true accommodating and astigmatism-correcting monofocal intraocular lens (IOL) for patients with cataracts. Self-described as a leader in accommodating IOL technology.

JelliSee

LensGen is an ophthalmic medical device company developing a curvature changing fluid lens to address presbyopia and cataracts.

LensGen

Medical Practices

LENTIS & FEMTIS intraocular lenses

Medical Equipment Manufacturing

ACUNEX intraocular lenses

Teleon  | 1,813 followers on LinkedIn. Passion for Perfect Vision | PASSION FOR PERFECT VISION

With the ACUNEX®, LENTIS® and FEMTIS® Brands, Teleon offers state-of-the-art cataract and refractive IOL-solutions.

Let your patients benefit from the market‘s most innovative IOL platform and one of the world‘s leading multifocal technologies. 800.000 multifocal implants worldwide speak for themselves.

R&D Polymer Scientist at Procornea Nederland B.V.

Giuseppe Caroli

Sales Director Germany bei Teleon

Markus Scheidt

Managing Director Teleon Holding B.V./ Teleon Surgical B.V.

Harald Ligt

HR Adviseur

Kim Konings

Teleon

One more ophthalmology pearl awaits in 2024: #SASCRS the 20th Biennial International Congress on Ophthalmology hosted by the Southern African Society of Cataract & Refractive Surgery and Teleon invites all interested parties to a lunch symposium with Prof. Dr. Thomas Kohnen Oliver Findl & Dr.Magda Rau 💚

Want to upgrade your practice with premium IOLs? At the Teleon booth during ESCRS 2024, Dr. Florian Tobias Alwin Dr. med. Kretz and Dr. DR. DETLEV R.H. BREYER, FWCRS shared game-changing tips on enhancing patient care with Teleon’s ACUNEX®, LENTIS® and FEMTIS® IOLs. From treating every patient like a premium candidate to consistently achieving next-level outcomes, their insights could transform your approach and elevate your ophthalmic business. Watch the full booth talk now at https://lnkd.in/gPziiUm4 and get inspired! The European Society of Cataract and Refractive Surgeons (ESCRS) #Teleon #IOLs #ESCRS2024 #MediaMICE

Matt Y.

Glaucoma treatment on a new level - Burkhard Dick unveiled femto-second laser-assisted non-invasive trabeculotomy during our #ESCRS2024 booth talks marathon! #vialase ViaLase, Inc https://lnkd.in/ezem22wd

As part of the Teleon -Booth Talk Marathon @ESCRS2024 in Barcelona, refractive IOL expert Prof. Corinne Dot shared the visual & refractive outcomes of a single-center cohort study with the pioneers of EDoF IOL-technology: LENTIS Comfort & LENTIS Comfort Toric. https://lnkd.in/epJDT3S2

Day 2 of #DOG2024 starts! Join us at our booth and learn more about intraocular lenses and electrophysiology by Roland Consult Stasche & Finger GmbH 💚

#DOG2024 starts now! The Teleon team stands ready: Mark Lansu, Dirk Schneider & Daniel Förtsch 💚 and KallEYE🤖

🤖💚 is beating already 😉 #DOG2024 built-up time. The DOG starts on 10 October 2024 in the Estrel Berlin Congress halls and Teleon will of course be there. DOG – the German Society of Ophthalmology is the medical scientific association of ophthalmology in Germany. It unites more than 8.000 ophthalmologists in hospitals, medical and research units. This year we will be represented with 2 booths at the DOG: the Teleon main stand in Hall Europa, booth E.16 and a second stand in Hall 2, booth H.42. As always, we will be presenting cutting-edge solutions for eye surgery – this year's highlights include our IOL product range, the new ViaLuxe laser system for the treatment of glaucoma and the RETI port/scan 21 from Roland Consult. Visit us at the DOG in Berlin. We look forward to seeing you there. Musik: Last Night Musiker: Marco Lazovic icons8.com/music/

Enrico Plessow

#DOG2024 in Berlin, 10-13 October. Visit us! Musik: Let the Mystery Unfold Musiker: geoffharvey

Metric
Company Name	Teleon Surgical BV	Bausch Surgical	JelliSee	LensGen
Symbol
MSH ID	COM:TELEON-SURGICAL	COM:ACUFOCUS	COM:JELLISEE	COM:LENSGEN
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical Devices	Medical Devices	Medical Devices	Medical Devices
Country	NL	US	US	US
Stage				Venture Round
Employee Count
Website	teleon-surgical.com	acufocus.com	jellisee.com	lensgen.com
LinkedIn	teleonsurgical			lensgen-inc.
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic				184
Web Traffic Growth				-0.88
Valuation
Raised Capital				10M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

TELE

COM:TELEON-SURGICAL

Teleon Surgical BV

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue